Dicerna to begin clinical development of DCR-A1AT for A1AT deficiency-associated liver disease

This article was originally published here

A1AT deficiency is a genetic disorder that can cause liver disease in children and adults, leading to complications such as weight loss, fatigue, jaundice and life-threatening conditions such

The post Dicerna to begin clinical development of DCR-A1AT for A1AT deficiency-associated liver disease appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply